Gastric Ulcer Treatment Guidelines
Initial Pharmacological Management
- The American College of Gastroenterology recommends initiating PPI therapy as soon as gastric ulceration is diagnosed, using standard doses: omeprazole 20mg, lansoprazole 30mg, or pantoprazole 40mg once daily for 6-8 weeks to achieve complete mucosal healing 1
- For actively bleeding ulcers, administer high-dose PPI therapy: 80mg bolus followed by 8mg/hour continuous infusion for 72 hours, then transition to standard oral PPI therapy, as recommended by the American College of Gastroenterology 1
- Perform urgent endoscopy for diagnosis and hemostasis—PPIs should not replace endoscopy in active bleeding, according to the American Society for Gastrointestinal Endoscopy 1
- Pre-endoscopy erythromycin improves visualization and reduces need for repeat procedures, as suggested by the American College of Gastroenterology 1
Helicobacter pylori Testing and Eradication
- The American College of Gastroenterology recommends testing all gastric ulcer patients for H. pylori infection, as failure to eradicate leads to 40-50% recurrence rates over 10 years 1
- Confirm eradication after completing treatment to prevent recurrence, as advised by the Infectious Diseases Society of America 1
- For areas with low clarithromycin resistance, standard triple therapy for 14 days is recommended: PPI standard dose twice daily + clarithromycin 500mg twice daily + amoxicillin 1000mg twice daily (or metronidazole 500mg twice daily if penicillin-allergic), according to the American College of Gastroenterology 1
- For areas with high clarithromycin resistance, sequential therapy for 10 days is recommended: Days 1-5 with PPI twice daily + amoxicillin 1000mg twice daily, then Days 6-10 with PPI twice daily + clarithromycin 500mg twice daily + metronidazole 500mg twice daily, as suggested by the European Helicobacter Study Group 1
NSAID-Associated Gastric Ulcers
- The American College of Gastroenterology recommends discontinuing NSAID therapy whenever clinically feasible, as this is the most effective intervention 1
- If NSAIDs must be continued, maintain PPI therapy long-term to prevent recurrence, as advised by the American College of Rheumatology 1
Common Pitfalls and Clinical Caveats
- The American College of Gastroenterology advises never skipping H. pylori testing—this single omission accounts for the majority of treatment failures and recurrences 1
- Do not use PPIs as a substitute for urgent endoscopy in patients with signs of active bleeding (hematemesis, melena, hemodynamic instability), according to the American Society for Gastrointestinal Endoscopy 1
- Avoid H2-receptor antagonists as first-line therapy—standard doses are ineffective for gastric ulcers, and even double doses show limited benefit primarily in H. pylori-positive patients, as reported by the American Gastroenterological Association 2
- PPIs may reduce absorption of medications requiring acidic environments (e.g., ketoconazole, iron, certain antiretrovirals), according to the American College of Clinical Pharmacy 1